Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Osteoporosis Reports
Erschienen in: Current Osteoporosis Reports 3/2011

01.09.2011

A Review of Osteoporosis Diagnosis and Treatment Options in New and Recently Updated Guidelines on Case Finding Around the World

verfasst von: William D. Leslie, John T. Schousboe

Erschienen in: Current Osteoporosis Reports | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Fracture rates are known to vary by more than an order of magnitude worldwide; therefore, a single approach cannot be universally applied to all countries. National considerations must reflect the burden of osteoporosis, available resources, the disease costs to the individual and society, and how these relate to competing health and other societal priorities. Recent developments in terms of diagnosis, fracture risk prediction, and therapeutic options have prompted many countries to review and update their clinical practice guidelines (CPGs) for the prevention and management of osteoporosis intended for use in primary care in the general adult population. This paper reviews recently updated CPGs from the following countries: Australia, Belgium, Canada, Germany, the United Kingdom, and the United States.
Literatur
1.
2.
Kanis JA, Melton III LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–41.PubMedCrossRef
3.
Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8(5):468–89.PubMedCrossRef
4.
Kanis JA, McCloskey EV, Johansson H, Oden A, Melton III LJ, Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42(3):467–75.PubMedCrossRef
5.
Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–33.PubMedCrossRef
6.
7.
Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res. 2003;18(11):1947–54.PubMedCrossRef
8.
Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos M. Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporosis International. 2001;12:271–8.PubMedCrossRef
9.
Papaioannou A, Adachi JD, Parkinson W, Stephenson G, Bedard M. Lengthy hospitalization associated with veretebral fractures despite control for comorbid conditions. Osteoporosis International. 2001;12(10):870–4.PubMedCrossRef
10.
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353(9156):878–82.PubMedCrossRef
11.
Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15(1):38–42.PubMedCrossRef
12.
Ioannidis G, Papaioannou A, Hopman WM, Khtar-Danesh N, Anastassiades T, Pickard L, et al. Relation between fractures and mortality: results from the Canadian multicentre osteoporosis study. CMAJ. 2009;181(5):265–71.PubMedCrossRef
13.
Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby AK. The components of excess mortality after hip fracture. Bone. 2003;32(5):468–73.PubMedCrossRef
14.
Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B. Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int. 2004;15(2):108–12.PubMedCrossRef
15.
Adachi JD, Ioannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001;12(11):903–8.PubMedCrossRef
16.
Hallberg I, Rosenqvist AM, Kartous L, Lofman O, Wahlstrom O, Toss G. Health-related quality of life after osteoporotic fractures. Osteoporos Int. 2004;15(10):834–41.PubMedCrossRef
17.
Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17(7):1237–44.PubMedCrossRef
18.
Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD. Low bone mineral density and fracture burden in postmenopausal women. CMAJ. 2007;177(6):575–80.PubMedCrossRef
19.
Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18(8):1033–46.PubMedCrossRef
20.
•• Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E. FRAX and its applications to clinical practice. Bone 2009 May;44(5):734–43. An introduction to the WHO FRAX system that is transforming osteoporosis CPGs. FRAX integrates the influence of several well-validated risk factors for fracture with or without the use of BMD. Its use in fracture risk prediction is changing patient assessment, the evaluation of drug efficacy and reimbursement, as well as for health economics.PubMedCrossRef
21.
Dawson-Hughes B. A revised clinician’s guide to the prevention and treatment of osteoporosis. J Clin Endocrinol Metab. 2008;93(7):2463–5.PubMedCrossRef
22.
Dawson-Hughes B, Tosteson AN, Melton III LJ, Baim S, Favus MJ, Khosla S, et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008;19(4):449–58.PubMedCrossRef
23.
Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385–97.PubMedCrossRef
24.
Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A. Case finding for the management of osteoporosis with FRAX((R))-assessment and intervention thresholds for the UK. Osteoporos Int. 2008;19(10):1395–408.PubMedCrossRef
25.
Lippuner K, Johansson H, Kanis JA, Rizzoli R. FRAX assessment of osteoporotic fracture probability in Switzerland. Osteoporos Int. 2010;21(3):381–9.PubMedCrossRef
26.
Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2008;19(4):399–428.PubMedCrossRef
27.
Fujiwara S, Kasagi F, Masunari N, Naito K, Suzuki G, Fukunaga M. Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res. 2003;18(8):1547–53.PubMedCrossRef
28.
Neuprez A, Johansson H, Kanis JA, McCloskey EV, Oden A, Bruyere O, et al. A FRAX model for the assessment of fracture probability in Belgium. Rev Med Liege. 2009;64(12):612–9.PubMed
29.
• Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010 Nov 23;182(17):1864–73. The Canadian CPG covers prevention, diagnosis and therapy of primary osteoporosis and common forms of secondary osteoporosis in adult women and men.PubMedCrossRef
30.
•• The AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003 Feb;12(1):18–23. AGREE is an international collaboration of researchers and policy makers who seek to improve the quality and effectiveness of CPGs by establishing a shared framework for their development, reporting, and assessment.CrossRef
31.
•• Scott NA, Moga C, Harstall C. Making the AGREE tool more user-friendly: the feasibility of a user guide based on Boolean operators. J Eval Clin Pract 2009 Dec;15(6):1061–73. A Boolean-based approach to rating guidelines under the AGREE system. Good reliability has been achieved in feasibility tests.PubMedCrossRef
32.
• Royal Australian College of General Practitioners RACGP. Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and men. 2010. Melbourne, Royal Australian College of General Practitioners RACGP. A literature review and CPG conducted on behalf of The Royal Australian College of General Practitioners to inform the development of an evidence-based CPG. The objective was to present the most recent evidence related to the management of osteoporosis to inform the development of evidence-based recommendations for general practitioners working in the Australian health care setting.
33.
Royal Australian College of General Practitioners RACGP. Osteoporosis: a literature review of recent evidence in postmenopausal women and older men. 2010. Melbourne, Royal Australian College of General Practitioners RACGP.
34.
• Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, et al. Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporos Int 2010 Oct;21(10):1657–80. The Belgian Bone Club is a nonprofit scientific organization devoted to promoting understanding of osteoporosis and bone diseases. Several statements have been developed to cover common clinical problems in the management of osteoporosis.PubMedCrossRef
35.
Body JJ, Bergmann P, Boonen S, Boutsen Y, Bruyere O, Devogelaer JP, et al. Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club. Osteoporos Int 2011 Mar 1.
36.
Devogelaer JP, Goemaere S, Boonen S, Body JJ, Kaufman JM, Reginster JY, et al. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int. 2006;17(1):8–19.PubMedCrossRef
37.
Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ. 2002;167(10 Suppl):S1–S34.PubMed
38.
• Schattauer 2011. DVO Guideline 2009 for Prevention, Diagnosis and Therapy of Osteoporosis in Adults. 2011. Germany, Schattauer 2011. The DVO is the osteology umbrella organization of the scientific societies for Germany, Austria, and Switzerland. The 2009 update of the CPGs for the prevention, diagnosis, and therapy of osteoporosis in adults targets primary care and specialist physicians who are clinically involved in the care of persons with osteoporosis, and provides recommendations on both primary osteoporosis and common forms of secondary osteoporosis.
39.
McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics. 2008;26(9):733–44.PubMedCrossRef
40.
• National Institute for Health and Clinical Excellence (NICE). Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (amended). 2011. London, National Institute for Health and Clinical Ecellence NHS. The UK NICE performed 16 systematic reviews of clinical effectiveness on “Osteoporosis: assessment of fracture risk and the prevention of osteoporotic fractures in individuals at high risk,” which are published as evidence reviews.
41.
National Institute for Health and Clinical Excellence (NICE). Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended). 2011. London, National Institute for Health and Clinical Ecellence NHS.
42.
National Institute for Health and Clinical Excellence (NICE). Denosumab for the prevention of osteoporotic fractures in postmenopausal women. 2010. London, National Institute for Health and Clinical Ecellence NHS.
43.
National Institute for Health and Clinical Excellence (NICE). Clinical practice guideline for the assessment and prevention of falls in older people. 2004. London, National Institute for Health and Clinical Ecellence NHS.
44.
• National Osteoporosis Guideline Group (NOGG). Osteoporosis Clinical guidelines for prevention and treatment Executive Summary. 2010. UK, National Osteoporosis Guideline Group (NOGG). The UK NOGG reviewed the assessment and diagnosis of osteoporosis, the therapeutic agents available, and the manner in which these can be used to develop management strategies for the prevention of osteoporotic fracture in postmenopausal women and in men ages over 50 years.
45.
• Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 2010 Nov;16 Suppl 3:1–37. Update of the 2004 AACE recommendations on diagnosis and treatment of postmenopausal osteoporosis.PubMed
46.
Dawson-Hughes B, Looker AC, Tosteson AN, Johansson H, Kanis JA, Melton III LJ. The potential impact of new national osteoporosis foundation guidance on treatment patterns. Osteoporos Int. 2010;21(1):41–52.PubMedCrossRef
47.
• U.S.Preventive Services Task Force. Screening for osteoporosis: U.S. Preventive services task force recommendation statement. Ann Intern Med 2011 Mar 1;154(5):356–64. Update of the 2002 USPSTF recommendations on screening for osteoporosis. The USPSTF evaluated evidence on the diagnostic accuracy of risk assessment instruments for osteoporosis and fractures, the performance of DXA and peripheral bone measurement tests in predicting fractures, the harms of screening for osteoporosis, and the benefits and harms of drug therapy for osteoporosis in women and men.
48.
Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: an update for the U.S. preventive services task force. Ann Intern Med. 2010;153(2):99–111.PubMed
Metadaten
Titel
A Review of Osteoporosis Diagnosis and Treatment Options in New and Recently Updated Guidelines on Case Finding Around the World
verfasst von
William D. Leslie
John T. Schousboe
Publikationsdatum
01.09.2011
Verlag
Current Science Inc.
Erschienen in
Current Osteoporosis Reports / Ausgabe 3/2011
Print ISSN: 1544-1873
Elektronische ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-011-0060-5

Weitere Artikel der Ausgabe 3/2011

Current Osteoporosis Reports 3/2011 Zur Ausgabe

ReviewPaper

The Role of Risk Communication in the Care of Osteoporosis

ReviewPaper

The Role of Falls in Fracture Prediction

ReviewPaper

Effects of Anti-osteoporosis Medications on Fracture Healing

ReviewPaper

Diagnostic Thresholds in Osteoporosis: How Are They Used in Clinical Trials?

ReviewPaper

Osteoporosis: A Paradox in Ankylosing Spondylitis

ReviewPaper

Minor, Major, Low-Trauma, and High-Trauma Fractures: What Are the Subsequent Fracture Risks and How Do They Vary?

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise